Press Release Description
Cancer Profiling Market Gains Momentum Amid Rising Cancer Cases
The Global Cancer Profiling Market is projected to grow at a CAGR of about 11.5% during the forecast period of 2024-30, cites MarkNtel Advisors in the recent research report. The rising inclination of consumers toward personalized medicine for cancer treatment in recent years has been supporting the growth of the market. Personalized medicine represents a groundbreaking approach to healthcare, where treatments are meticulously customized based on an individual's distinctive genetic, environmental, and lifestyle attributes, ensuring precision and effectiveness.
The growing awareness among consumers regarding the superior efficacy of personalized medicine, particularly in cancer treatment, has spurred demand, notably in countries such as the US, India, and the UK. Simultaneously, the escalating incidence of cancers like breast and ovarian cancer in countries like China, Canada, and Australia due to factors like lifestyle, environmental conditions, and genetic mutations has amplified the necessity for personalized medicines in these regions. Consequently, the development of personalized cancer treatments has driven the growth of the Global Cancer Profiling Market, which plays a crucial role in identifying various biomarkers during the development phases.
Further, in recent years, companies such as Amazon, M2GEN, and FOXO Technologies have been actively dedicated to enhancing their bioinformatics software and services, with a particular focus on the oncology sector. These services are meticulously crafted to deliver swift, highly dependable, and secure software solutions for processing and analyzing extensive genomic and proteomic data.
The introduction of advanced bioinformatics tools and services in the Cancer Profiling Market has paved the way for the development of a diverse range of cancer research and diagnostic solutions. Companies have recently shifted their attention to key areas such as targeted therapies and drug discovery. Consequently, as these companies roll out advanced bioinformatics services, they are expected to significantly enhance the outcomes of cancer research and diagnostics through improved tumor profiling. This, in turn, will boost the efficiency and turnaround time for companies operating in the market, creating substantial growth opportunities in the years ahead, further states the research report, “Global Cancer Profiling Market Analysis, 2024.”
Prostate Cancer Segment Leading the Market
Based on the type of cancer, the market is further bifurcated into, Breast Cancer, Colorectal Cancer, Gynecological Cancer, Leukemia, Prostate Cancer, Lung Cancer, and others (Pancreatic Cancer, Skin Cancer, etc.). Among all cancer types, the prostate cancer segment holds the largest share in the Global Cancer Profiling Market, primarily due to its increasing prevalence on a global scale.
Prostate cancer has consistently ranked as one of the most common forms of cancer affecting men, underscoring the critical importance of early diagnosis for tailored treatment approaches. Notably, prostate cancer patients have exhibited a strong inclination towards utilizing cancer profiling services for both early detection and personalized therapeutic interventions. This preference is largely attributable to the advanced capabilities of these services, facilitating precise dosage optimization for treatment drugs and therapies.
Moreover, as the prevalence of prostate cancer continues to rise, researchers in countries such as the US, Germany, South Korea, and others have intensified their focus on this specific cancer category. Their efforts are directed towards developing advanced therapeutic modalities for addressing prostate cancer. This research-driven approach is expected to further drive the demand for cancer profiling services in the coming years.
North America Region Dominating the Cancer Profiling Market
Geographically, North America has consistently held a dominant position in the Global Cancer Profiling Market. This prevailing dominance can be primarily attributed to the unhealthy lifestyle choices made by consumers, which have resulted in a marked increase in cancer prevalence across the region. Consequently, the demand for comprehensive cancer panels and profiling has seen a proportionate increase due to the growing burden of cancer, thereby significantly contributing to the overall market's expansion in the region.
Moreover, the American Cancer Society has made projections indicating that cancer rates are anticipated to continue rising across the United States in the foreseeable future. This projection further solidifies the region's potential for continued dominance in the Global Cancer Profiling Market in the years to come.
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including NeoGenomics Laboratories, Eurofins Genomics GmbH, F. Hoffmann-La Roche Ltd (Foundation Medicine), OncoDNA SA, 10x Genomics, Inc., Caris Life Sciences., Geneseeq Technology Inc., Genetron Holdings Limited, Laboratory Corporation of America Holdings (LabCorp), Dante Labs Inc., Celemics, Inc., Strand Life Sciences, Myriad Genetics, Inc., QIAGEN GmbH, Tempus Labs and Others are looking forward to strengthening their market position.
Key Questions Answered in the Research Report
- What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- What key factors would propel and impede the industry across the Globe?
- How has the industry been evolving in terms of geography & service adoption?
- How has the competition been shaping across various regions?
- How have the buying behavior, customer inclination, and expectations from service providers been evolving during 2019-30?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
Place an order
100% Safe & Secure
Strongest encryption on the website to make your purchase safe and secure